Testosterone Lawsuit Attorneys at Bernstein Liebhard LLP Look Ahead to June Conference in Federal Multidistrict Litigation

New York, New York (PRWEB) May 24, 2015

The federal court overseeing hundreds of testosterone treatment lawsuits (http://www.testosteronelawsuithub.com/) has scheduled its next monthly Case Management Conference to discuss the progress of the multidistrict litigation. According to court documents filed in the U.S. District Court, Northern District of Illinois, the Conference will be convened on June 2, 2015, at 1:30 p.m. (In re: Testosterone Replacement Therapy Product Liability Litigation – MDL No. 2545)

“Our Firm is representing clients who have filed testosterone lawsuits in this proceeding. We are looking forward to the June 2nd Conference, as it will likely include discussions regarding discovery, bellwether trial selection and other matters that could impact our clients’ cases,” says Sandy A. Liebhard, a partner at Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm continues to offer free case reviews to men who may have been harmed by low testosterone therapy medications.

Testosterone Litigation

According to court documents, more than 1,400 testosterone lawsuits have been filed in the federal litigation underway in Illinois. The litigation was established in June 2014, several months after the U.S. Food & Drug Administration’s (FDA) announced that it was conducting a review of the cardiovascular risks potentially associated with the use of testosterone replacement therapy.* The results of that review were announced by the FDA on March 3, 2015, at which time the agency ordered the manufacturers of prescription testosterone treatments to modify their labels with information regarding a potential association with an increased risk of heart attack and stroke.

Court documents indicate that all of the claims pending in the federal litigation allege the manufacturers of testosterone replacement medications concealed their alleged association with heart attacks, strokes, blood clots and other life-threatening complications. Plaintiffs further assert that sales of low testosterone therapy products were driven by misleading marketing claims that positioned the drugs as safe and effective treatments for low libido, muscle loss, fatigue and other symptoms commonly associated with male aging, even though they have never been approved by the FDA for this purpose.

Men who allegedly experienced dangerous cardiovascular complications due to their use of low testosterone treatments may be entitled to compensation for medical bills, lost wages, pain and suffering, and more. To learn more about filing a testosterone treatment lawsuit, please visit Bernstein Liebhard LLP’s website. Free, no-obligation legal consultations can be obtained by calling 800-511-5092.

*http://www.fda.gov/Drugs/DrugSafety/ucm383904.htm, FDA, January 31, 2014

About Bernstein Liebhard LLP

Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $ 3 billion on behalf of our clients. The National Law Journal has recognized Bernstein Liebhard for twelve consecutive years as one of the top plaintiffs’ firms in the country. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP

10 East 40th Street

New York, New York 10016

800-511-5092

ATTORNEY ADVERTISING. © 2015 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:

Sandy A. Liebhard, Esq.

Bernstein Liebhard LLP

info (at) consumerinjurylawyers (dot) com

http://www.testosteronelawsuithub.com/

https://plus.google.com/115936073311125306742?rel=author







DePuy ASR Lawsuit News: Federal Court Extends Deadline on Tolling Agreements for Non-Revision Plaintiffs, Bernstein Liebhard LLP Reports

New York, New York (PRWEB) December 28, 2014

The federal court overseeing thousands of DePuy ASR hip lawsuits (http://www.consumerinjurylawyers.com/DePuy/) has extended the deadline by which non-revision plaintiffs must decide to enter into a tolling agreement with Johnson & Johnson and its DePuy Orthopaedics unit, Bernstein Liebhard LLP reports. According to an Order posted December 24th on the website for the U.S. District Court, Northern District Ohio, such plaintiffs must now notify the Court by January 31, 2015 if they intend to continue with their case or voluntarily dismiss their lawsuit. Per an earlier court Order, plaintiffs who opt for voluntarily dismissal would enter into a tolling agreement with the defendants that would call for the refiling of their claim should they require revision of their ASR hip implant in the future.* (In re: DePuy Orthopaedics, Inc. ASR Hip Implant Products Liability Litigation – MDL 2197)

“We are representing numerous plaintiffs who have filed lawsuits in this proceeding. As non-revision plaintiffs are not eligible to participate in the settlement program announced last year, entering into a tolling agreement may be a viable option for these individuals,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices.

The Firm continues to offer free legal evaluations to individuals who allegedly experienced metallosis, chronic pain, disability, premature hip implant failure, and other serious complications allegedly related to devices included in the DePuy ASR recall.

DePuy ASR Litigation

According to court documents, the DePuy ASR hip recall was announced in August 2010, after data indicated that the metal-on-metal hips were failing at an unacceptably high rate within just five years of implantation. Since then, thousands of product liability claims have been filed in state and federal courts on behalf of individuals who allegedly suffered serious complications due to their ASR hips, most of which have been consolidated in a multidistrict litigation established in the Northern District of Ohio.

Last November, the Court announced the establishment of the DePuy ASR settlement program, which could ultimately resolve the majority of cases pending in state and federal courts. However, those eligible to participate in the program were limited to DePuy ASR recipients who underwent revision surgery to replace their implant due to a recall-related reason prior to August 31, 2013.

Individuals who allegedly suffered serious complications related to the DePuy ASR recall may be entitled to compensation for their injury-related damages. To learn more about the DePuy ASR litigation, please visit Bernstein Liebhard LLP’s website. For a free, no obligation case review, please call the Firm directly at 800-511-5092.

*ohnd.uscourts.gov/assets/CMO-24A.pdf, U.S. District Court, Northern District of Ohio, December 24, 2014

About Bernstein Liebhard LLP

Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $ 3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP

10 East 40th Street

New York, New York 10016

800-511-5092

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:

Felecia L. Stern, Esq.

Bernstein Liebhard LLP

info (at) consumerinjurylawyers (dot) com

http://www.consumerinjurylawyers.com

https://plus.google.com/115936073311125306742?rel=author







Security Industry Association Delivers Recommendations for Cameras Onboard Trains to Federal Railroad Administration

Silver Spring, Md. (PRWEB) November 06, 2014

The Security Industry Association (SIA) recently presented recommendations for the adoption of image and audio recording technologies to strengthen investigations and accident prevention efforts onboard U.S. passenger and freight trains before an advisory committee of the Federal Railroad Administration.

The newly formed SIA Transportation Policy Working Group made its recommendations by invitation on Oct. 29 to the FRA Rail Safety Advisory Committee (RSAC), which is formulating a federal requirement for equipping lead train cabs with cameras and recording devices. RSAC was formed in 1996 to develop regulatory proposals to address safety issues, comprised of both public and private stakeholders within the rail community.

The SIA presentation provided an overview of available technology provided by the security industry for rail and mass transit applications and addressed long-term technology considerations RSAC may wish to consider. It focused on the importance of maintaining interoperable interfaces and capability to integrate with other train systems as well as detailed technology building blocks, such as high-quality images and secure data storage, which are necessary to accomplish the goals outlined by the FRA.

These goals include improving accident/incident investigation, evaluation of employee fatigue, distraction and interaction, and providing assistance for employee training and testing.

“A carefully considered requirement for camera technology onboard passenger and freight trains would go a long way to ensuring the safety and security of people and material traveling U.S. railways,” said SIA Director of Government Relations Jake Parker. “The security industry is ready to assist our nation’s railroads in preventing and mitigating any accidents, crimes or disasters along our railways.”

Parker is available to discuss the importance of audio and video technologies to railroad safety and security in response to media requests. The SIA presentation to RSAC is available online at http://www.securityindustry.org/SiteAssets/GovernmentRelations/Capital%20Perspective%20Briefings/SIA%20RSAC%20Presentation.pdf.

The National Transportation Safety Board (NTSB) has recommended using image and audio recording technologies to strengthen investigations and accident prevention efforts in response to an alarming number of recent fatal rail incidents throughout the country—in Chatsworth, Calif.; Red Oak, Iowa; the Bronx in New York City, and other locations.

In March 2014, the FRA tasked RSAC with developing a federal requirement for the adoption of recording technologies by trains, to be reported by April 1, 2015. The next meetings to address this issue are scheduled for Dec. 9 and 10 at the National Housing Center, 1201 15th St., NW, Washington D.C. The meetings are open to the public.

About the Security Industry Association

The Security Industry Association (SIA) (http://www.securityindustry.org) is the leading trade association for electronic and physical security solution providers, with more than 500 innovative member companies representing more than 300,000 security leaders and experts who shape the future of the security industry. SIA protects and advances its members’ interests by advocating pro-industry policies and legislation at the federal and state levels; creating open industry standards that enable integration; advancing industry professionalism through education and training; opening global market opportunities; and collaboration with other like-minded organizations. As a proud sponsor of ISC Events expos and conferences, and owner of the Securing New Ground® conference, SIA ensures its members have access to top-level buyers and influencers, as well as unparalleled learning and network opportunities.







Find More Accident Press Releases

Vaginal Mesh Lawsuit News: Boston Scientific Loses Bid for Summary Judgment on Negligence, Warning Claims in Federal Obtryx Case, Bernstein Liebhard LLP Reports

New York, New York (PRWEB) October 23, 2014

The federal judge overseeing thousands of vaginal mesh lawsuits (http://www.consumerinjurylawyers.com/transvaginal-mesh-recall-lawsuit.html) filed against Boston Scientific Corp. has denied the company’s Motion for Summary Judgment on negligence and warning claims put forth in one case involving the Obtryx Transobturator Mid-Urethral Sling System. The lawsuit, which is currently pending in the federal multidistrict litigation now underway in the U.S. District Court, Southern District of West Virginia, claims that the Obtryx device caused the plaintiff to suffer erosion, mesh contraction, infection, fistula, inflammation, scar tissue, organ perforation, and other serious vaginal mesh complications. According to an Order issued on October 17th, Judge Joseph R. Goodwin allowed her failure to warn, negligence and breach of warranty claims to go forward after finding that the lawsuit had established issues of fact as to the safety and effectiveness of the device. (Tyree, et al. v. Boston Scientific Corp., No. 2:12-8633)

According to court documents, this lawsuit is one of four Boston Scientific cases involving Obtryx mesh that have been consolidated for the proceeding’s first bellwether trial. That trial is scheduled to begin on November 3, 2014.

“Our Firm is closely monitoring the progress of vaginal mesh lawsuits filed against Boston Scientific Corp. and other companies, as we are representing hundreds of women in claims that put forth similar allegations,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm continues to offer free legal reviews to women who suffered mesh erosion, pain, scarring, infection and other serious transvaginal mesh complications, allegedly due to products marketed by a number of manufacturers.

Transvaginal Mesh Litigation

Court records indicate that Boston Scientific has been named a defendant in more than 14,000 vaginal mesh lawsuits that are currently pending in the Southern District of West Virginia. Bernstein Liebhard LLP partner, Jeffrey S. Grand, is serving as a member of the Plaintiffs’ Steering Committee for this proceeding. All the claims filed in this litigation similarly allege that pelvic mesh products marketed by Boston Scientific were defectively designed and manufactured, and caused women to suffer a wide variety of painful and debilitating transvaginal mesh complications. (In re: Boston Scientific Corp., Pelvic Repair Systems Products Liability Litigation – MDL No. 2326)

Court records indicate that more than 60,000 transvaginal mesh lawsuits are currently pending in several litigations underway in the Southern District of West Virginia. Mr. Grand isalso a member of the Plaintiffs’ Steering Committee for other federal proceedings, including those involving American Medical Systems, Inc. (MDL No. 2325), C.R. Bard, Inc. (MDL 2326) and Ethicon, Inc. (MDL No. 2327).

Mr. Grand was also appointed Co-Liaison Counsel in two multicounty litigations established for C.R. Bard and Ethicon mesh lawsuits in New Jersey’s Atlantic Superior Court. He was also a member of the trial team on the first Ethicon trial, which ended in March 2013 with an $ 11 million verdict for the Plaintiff. (In re: Pelvic Mesh/Gynecare Litigation, No. 6341-10; In re: Pelvic Mesh Litigation/Bard, No. L-6339-10)

Women who were allegedly harmed by pelvic mesh products used to treat pelvic organ prolapse or stress urinary incontinence may be entitled to pursue a legal claim against the manufacturer of the device. To learn more about filing a vaginal mesh lawsuit, please visit Bernstein Liebhard LLP’s website or the firm’s Facebook page: https://www.facebook.com/meshlawsuit. To arrange for a free legal consultation, please call 800-511-5092

About Bernstein Liebhard LLP

Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $ 3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP

10 East 40th Street

New York, New York 10016

800-511-5092

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:

Felecia L. Stern, Esq.

Bernstein Liebhard LLP

info(at)consumerinjurylawyers(dot)com

http://www.consumerinjurylawyers.com

https://plus.google.com/115936073311125306742?rel=author







Find More Legal Press Releases